Development and Psychometric Evaluation of the Self-Efficacy for Appropriate Medication Use Scale (SEAMS) in Low-Literacy Patients With Chronic Disease

2007 ◽  
Vol 15 (3) ◽  
pp. 203-219 ◽  
Author(s):  
Jessica Risser ◽  
Terry A. Jacobson ◽  
Sunil Kripalani
Keyword(s):  
Chronic Disease ◽  
Medication Adherence ◽  
Disease Management ◽  
Internal Consistency ◽  
Self Efficacy ◽  
Chronic Disease Management ◽  
Medication Use ◽  
Literacy Skills ◽  
The Self ◽  
Low Literacy

Medication nonadherence remains a significant obstacle to achieving improved health outcomes in patients with chronic disease. Self-efficacy, the confidence in one’s ability to perform a given task such as taking one’s medications, is an important determinant of medication adherence, indicating the need for reliable and valid tools for measuring this construct. This study sought to develop a self-efficacy scale for medication adherence in chronic disease management that can be used in patients with a broad range of literacy skills. The Self-efficacy for Appropriate Medication Use (SEAMS) was developed by a multidisciplinary team with expertise in medication adherence and health literacy. Its psychometric properties were evaluated among 436 patients with coronary heart disease and other comorbid conditions. Reliability was evaluated by measuring internal consistency and test-retest reliability. Principal component factor analysis was performed to evaluate the validity of the SEAMS. Reliability and validity analyses were also performed separately among patients with low and higher literacy levels. The final 13-item scale had good internal consistency reliability (Cronbach’s α = 0.89). A two-factor solution was found, explaining 52.3% of the scale’s variance. The scale performed similarly across literacy levels. The SEAMS is a reliable and valid instrument that may provide a valuable assessment of medication self-efficacy in chronic disease management, and appears appropriate for use in patients with low literacy skills.

Self-management factors associated with quality of life among women with endometriosis: a cross-sectional Australian survey

2020 ◽  
Author(s):  
Rebecca O’Hara ◽  
Heather Rowe ◽  
Jane Fisher
Keyword(s):  
Quality Of Life ◽  
Chronic Disease ◽  
Disease Management ◽  
Self Efficacy ◽  
Chronic Disease Management ◽  
Self Management ◽  
Cross Sectional ◽  
Female Population ◽  
Management Factors

Abstract STUDY QUESTION What self-management factors are associated with quality of life among women with endometriosis? SUMMARY ANSWER Greater self-efficacy was associated with improved physical and mental quality of life. WHAT IS KNOWN ALREADY Women with endometriosis have an impaired quality of life compared to the general female population. However, most studies have investigated quality of life in a hospital or clinic setting rather than a community setting and the association between self-management factors and quality of life have not, to date, been investigated. STUDY DESIGN, SIZE, DURATION A cross-sectional, population-based online survey was performed, which was advertised through women’s, community and endometriosis-specific groups. PARTICIPANTS/MATERIALS, SETTING, METHODS A total of 620 women completed the survey for this study. Mental and physical quality of life was assessed using the standardized SF36v2 questionnaire. Self-management factors included self-efficacy, partners in health (active involvement in managing the condition) and performance of self-care activities. Treatment approaches included the use of hormonal treatment, pain medications and complementary therapies and whether the participant had a chronic disease management plan. Hierarchical regression analyses were used to examine whether self-management and treatment factors were associated with quality of life. MAIN RESULTS AND THE ROLE OF CHANCE Both physical and mental quality of life were significantly lower among women with endometriosis compared to the mean scores of the general Australian female population (P < 0.001). Physical quality of life was positively associated with income sufficiency (P < 0.001) and greater self-efficacy (P < 0.001), but negatively associated with age (P < 0.001), pain severity (P < 0.001), use of prescription medications (P < 0.001), having a chronic disease management plan (P < 0.05) and number of self-care activities (P < 0.05). Mental quality of life was positively associated with being older (P < 0.001), partnered (P < 0.001), having a university education (P < 0.05), increasing self-efficacy (P < 0.001) and higher partners in health scores (P < 0.001). LIMITATIONS, REASONS FOR CAUTION Results are derived from a cross-sectional study and can only be interpreted as associations not as causal relationships. The sample was more educated, more likely to speak English and be born in Australia than the general Australian female population of the same age, which may influence the generalizability of these results. WIDER IMPLICATIONS OF THE FINDINGS This study investigated a knowledge gap by investigating quality of life of women with endometriosis in a large community sample. Self-efficacy was significantly associated with both physical and mental quality of life. Supporting women with endometriosis to improve self-efficacy through a structured chronic disease management programme may lead to improvements in this aspect of wellbeing. STUDY FUNDING/COMPETING INTEREST(S) R.O. undertook this research as part of her PhD at Monash University, which was supported by an Australian Government Research Training Program Stipend. J.F. is the Finkel Professor of Global Public Health, which was supported by the Finkel Family Foundation. There are no conflicts of interest to declare. TRIAL REGISTRATION NUMBER NA.

scholarly journals Incorporating Behavioral Trigger Messages Into a Mobile Health App for Chronic Disease Management: Randomized Clinical Feasibility Trial in Diabetes

10.2196/15927 ◽  
2020 ◽  
Vol 8 (3) ◽  
pp. e15927
Author(s):  
Scott Sittig ◽  
Jing Wang ◽  
Sriram Iyengar ◽  
Sahiti Myneni ◽  
Amy Franklin
Keyword(s):  
Chronic Disease ◽  
Disease Management ◽  
Mobile Health ◽  
Self Efficacy ◽  
Chronic Disease Management ◽  
Text Messages ◽  
Feasibility Trial ◽  
Significant Difference ◽  
Within Subjects ◽  
The Impact

Background Although there is a rise in the use of mobile health (mHealth) tools to support chronic disease management, evidence derived from theory-driven design is lacking. Objective The objective of this study was to determine the impact of an mHealth app that incorporated theory-driven trigger messages. These messages took different forms following the Fogg behavior model (FBM) and targeted self-efficacy, knowledge, and self-care. We assess the feasibility of our app in modifying these behaviors in a pilot study involving individuals with diabetes. Methods The pilot randomized unblinded study comprised two cohorts recruited as employees from within a health care system. In total, 20 patients with type 2 diabetes were recruited for the study and a within-subjects design was utilized. Each participant interacted with an app called capABILITY. capABILITY and its affiliated trigger (text) messages integrate components from social cognitive theory (SCT), FBM, and persuasive technology into the interactive health communications framework. In this within-subjects design, participants interacted with the capABILITY app and received (or did not receive) text messages in alternative blocks. The capABILITY app alone was the control condition along with trigger messages including spark and facilitator messages. A repeated-measures analysis of variance (ANOVA) was used to compare adherence with behavioral measures and engagement with the mobile app across conditions. A paired sample t test was utilized on each health outcome to determine changes related to capABILITY intervention, as well as participants’ classified usage of capABILITY. Results Pre- and postintervention results indicated statistical significance on 3 of the 7 health survey measures (general diet: P=.03; exercise: P=.005; and blood glucose: P=.02). When only analyzing the high and midusers (n=14) of capABILITY, we found a statistically significant difference in both self-efficacy (P=.008) and exercise (P=.01). Although the ANOVA did not reveal any statistically significant differences across groups, there is a trend among spark conditions to respond more quickly (ie, shorter log-in lag) following the receipt of the message. Conclusions Our theory-driven mHealth app appears to be a feasible means of improving self-efficacy and health-related behaviors. Although our sample size is too small to draw conclusions about the differential impact of specific forms of trigger messages, our findings suggest that spark triggers may have the ability to cue engagement in mobile tools. This was demonstrated with the increased use of capABILITY at the beginning and conclusion of the study depending on spark timing. Our results suggest that theory-driven personalization of mobile tools is a viable form of intervention. Trial Registration ClinicalTrials.gov NCT04132089; http://clinicaltrials.gov/ct2/show/NCT004122089

scholarly journals Incorporating Behavioral Trigger Messages Into a Mobile Health App for Chronic Disease Management: Randomized Clinical Feasibility Trial in Diabetes (Preprint)

2019 ◽  
Author(s):  
Scott Sittig ◽  
Jing Wang ◽  
Sriram Iyengar ◽  
Sahiti Myneni ◽  
Amy Franklin
Keyword(s):  
Chronic Disease ◽  
Disease Management ◽  
Mobile Health ◽  
Self Efficacy ◽  
Chronic Disease Management ◽  
Text Messages ◽  
Feasibility Trial ◽  
Significant Difference ◽  
Within Subjects ◽  
The Impact

BACKGROUND Although there is a rise in the use of mobile health (mHealth) tools to support chronic disease management, evidence derived from theory-driven design is lacking. OBJECTIVE The objective of this study was to determine the impact of an mHealth app that incorporated theory-driven trigger messages. These messages took different forms following the Fogg behavior model (FBM) and targeted self-efficacy, knowledge, and self-care. We assess the feasibility of our app in modifying these behaviors in a pilot study involving individuals with diabetes. METHODS The pilot randomized unblinded study comprised two cohorts recruited as employees from within a health care system. In total, 20 patients with type 2 diabetes were recruited for the study and a within-subjects design was utilized. Each participant interacted with an app called capABILITY. capABILITY and its affiliated trigger (text) messages integrate components from social cognitive theory (SCT), FBM, and persuasive technology into the interactive health communications framework. In this within-subjects design, participants interacted with the capABILITY app and received (or did not receive) text messages in alternative blocks. The capABILITY app alone was the control condition along with trigger messages including spark and facilitator messages. A repeated-measures analysis of variance (ANOVA) was used to compare adherence with behavioral measures and engagement with the mobile app across conditions. A paired sample <i>t</i> test was utilized on each health outcome to determine changes related to capABILITY intervention, as well as participants’ classified usage of capABILITY. RESULTS Pre- and postintervention results indicated statistical significance on 3 of the 7 health survey measures (general diet: <i>P</i>=.03; exercise: <i>P</i>=.005; and blood glucose: <i>P</i>=.02). When only analyzing the high and midusers (n=14) of capABILITY, we found a statistically significant difference in both self-efficacy (<i>P</i>=.008) and exercise (<i>P</i>=.01). Although the ANOVA did not reveal any statistically significant differences across groups, there is a trend among spark conditions to respond more quickly (ie, shorter log-in lag) following the receipt of the message. CONCLUSIONS Our theory-driven mHealth app appears to be a feasible means of improving self-efficacy and health-related behaviors. Although our sample size is too small to draw conclusions about the differential impact of specific forms of trigger messages, our findings suggest that spark triggers may have the ability to cue engagement in mobile tools. This was demonstrated with the increased use of capABILITY at the beginning and conclusion of the study depending on spark timing. Our results suggest that theory-driven personalization of mobile tools is a viable form of intervention. CLINICALTRIAL ClinicalTrials.gov NCT04132089; http://clinicaltrials.gov/ct2/show/NCT004122089

scholarly journals The Use of Health IT for Chronic Disease Management: A comprehensive review of diabetes applications used for self-management of the disease (Preprint)

2019 ◽  
Author(s):  
Lorrin Robinson ◽  
Jamesa Hogges ◽  
Ingrid Brown ◽  
Kennedy Craig ◽  
Akasha Lawrence ◽  
...  
Keyword(s):  
Chronic Disease ◽  
Disease Management ◽  
Mobile Health ◽  
Chronic Disease Management ◽  
The Self ◽  
Self Management ◽  
Consumer Reviews ◽  
Health Apps ◽  
Apple Ios ◽  
Mobile Health Apps

BACKGROUND Mobile health (mHealth) smartphone applications (apps) have shown promise in the self-management of chronic disease. Management of key disease variances can be performed through these applications to increase patient engagement in disease self-management. In today’s oversaturated health app market, what selection criteria do consumers employ to choose mobile health apps for disease self-management? App quality is critical in monitoring disease controls but is often linked to consumer popularity rather clinical recommendations of effectiveness in disease management. This paper provides a comprehensive review of features found in mobile health apps frequently used in the self-management of diabetes. OBJECTIVE The objective of this study was to review features of frequently used and high consumer-rated mobile health apps used in the self-management of diabetes within the Apple iOS store. These applications were cross-referenced against high consumer-rated health apps found in other online diabetes sources. This study aimed to highlight key features of consumer-favored mobile health apps used in the self-management of diabetes. METHODS A primary Apple iOS store search was conducted using the term “diabetes apps” on an Apple iPad. The top five most frequently used mobile health apps were identified and rated by the number of consumer reviews, application ratings, and the presence of key diabetes management features: dietary blood glucose, A1C, insulin, physical activity and prescription medication. A subsequent Google search was conducted using the search term “best Apple diabetes apps”. The top three search results – Healthline, Everyday Health, and Diabetes Apps, American Diabetes Association – were explored. The top five frequently used apps among those sources were examined against the same Apple iOS criteria. RESULTS Twelve mobile health apps were reviewed in total due to repetition in popularity across the four evaluated sources. Only one health app – Glucose Buddy Diabetes Tracker – appeared most frequently used within the Apple iOS store and across the other three sources. The OneTouch Reveal app ranked first on the list in the iOS store with 39,000 consumer reviews and a rating of 4.7 out of 5.0 stars while only appearing once among the other sources. Blood glucose tracking was evident across all apps, but other disease management features varied in type with at least three of the five key features being present across the 12 reviewed apps. Subscription costs and integration needs were present which could play a major role in consumer app selection. While mobile app preference was assessed and defined by the number of consumer reviews and star ratings, there were no scientific standards used in the selection and ranking of the health apps within this study. CONCLUSIONS Mobile health applications (apps) have shown promise in chronic disease management, but a surge in development of these non-regulated health solutions points to a need for standards in quality. A governing body of health information technology, clinical, policymaking, and other industry stakeholders, including patients, could be beneficial in defining health application standards for effective chronic disease management. Variabilities in features, cost, and other management inconsistencies could be diminished by regulatory uniformity and increase both patient engagement activities and disease outcomes.

scholarly journals Association between participation in a chronic disease management program, medication adherence and decrease of blood pressure

2018 ◽  
Vol 6 (2) ◽  
pp. 119
Author(s):  
I Ketut Indra Wiguna Cakera ◽  
Ni Made Sri Nopiyani ◽  
I Made Ady Wirawan
Keyword(s):  
Blood Pressure ◽  
Chronic Disease ◽  
Medication Adherence ◽  
Disease Management ◽  
Disease Management Program ◽  
Chronic Disease Management ◽  
Management Program ◽  
Physical Activities ◽  
Community Based ◽  
Good Adherence

Background and purpose:The prevalence of hypertension is increasing globally. A comprehensive approach is necessary including a community based chronic disease management program which has been implemented in public health centres in Indonesia. Only few studies have been published in Indonesia that evaluate the program, especially regarding the management of hypertension in primary care settings. This study aims to examine the association between participation in a chronic disease management program, medication adherence and decrease of blood pressure.Methods: A cross-sectional study was conducted in public health centres in Tabanan District. A total of 136 patients with hypertension were recruited at five groups that participate in the community based chronic disease management program called Program Pengelolaan Penyakit Kronis (Prolanis). The Prolanis groups were purposively selected based on the size of participants in the program. One group was selected at urban area and four groups at rural areas. Data were collected from May to June 2017 by conducting interviews, blood pressure measurements, and secondary data extraction from the medical record of the Prolanis database. The logistic regression analysis was used to determine the association between participation in a chronic disease management program, medication adherence and decrease of blood pressure.Results: As many as 75.7% of respondents actively participated in the Prolanis Program, and 81.6% were found with decreased blood pressure. Our study found a significant association between blood pressure decrease and active participation in the Prolanis Program with an adjusted odds ratio (AOR) of 6.38 (95%CI: 1.96–20.79), the good adherence towards medication with AOR=11.94 (95% CI: 3.60–39.56), and routine physical activities with AOR=3.84 (95%CI: 1.16-12.73). Conclusion: Active participation in the Prolanis Program, good adherence to medication and routine physical activities are independent factors of decreased blood pressure. These findings suggest the need for scaling up the Prolanis Program and increasing its coverage.

scholarly journals P230 Development of a Japanese version of the IBD Self-Efficacy Scale and evaluation of its current status in Japan

2021 ◽  
Vol 15 (Supplement_1) ◽  
pp. S280-S280
Author(s):  
M Tanaka ◽  
A Kawakami ◽  
K Sakagami ◽  
T Terai ◽  
H Ito
Keyword(s):  
Disease Management ◽  
Internal Consistency ◽  
Self Efficacy ◽  
Japanese Version ◽  
Emotion Management ◽  
The Self ◽  
Self Management ◽  
Current Status ◽  
Group Validity ◽  
Maintenance Of Remission

Abstract Background In chronic diseases like inflammatory bowel disease (IBD), self-efficacy is one of important health outcomes. The IBD-Self-Efficacy Scale (IBD-SES) is an outcome measure used in research settings. In this study, we aimed to develop a Japanese version of IBD-SES and investigate the self-efficacy of IBD patients in Japan. Methods We conducted a questionnaire survey with IBD patients from two different sources: outpatients of a specialized IBD clinic and respondents recruited online. The original 29-item IBD-SES, with scores from 1 (not at all) to 10 (totally) in each item, and higher scores indicating greater self-management efficacy, was translated into Japanese with permission of the original author and was used for the surveys after confirming its linguistic equivalence with the original version. The reliability of the scale was assessed by calculating the Cronbach’s alpha coefficient for internal consistency, and the validity was assessed by disease activity (remission vs. active period) for known-group validity. Items of IBD-SES score comparison between the outpatient clinic group and online group were performed by t-test. Results A total of 919 valid responses were obtained, 482 patients (ulcerative colitis (UC): 184, Crohn’s disease (CD): 298) from the specialized IBD clinic and 437 (UC: 255, CD: 182) online. The mean score per item for each subscale [Stress & Emotion Management], [Outpatient care & medication management], [Symptom & disease management] and [Maintenance of remission] was 4.7, 7.3, 4.9, and 4.9, respectively. Internal consistency was confirmed on each subscale (Cronbach’s α: 0.85–0.94). Comparing remission and active periods, significant differences were observed in three subscales: [Stress & Emotion Management (p &lt; 0.001)], [Symptom & disease management (p &lt; 0.001)] and [Maintenance of remission (p &lt; 0.001)], and the known group validity was mostly confirmed. Conclusion This study demonstrates the reliability and validity of the Japanese version of the IBD-SES and reveals the current status of self-efficacy of the self-management of IBD patients in Japan. Compared to previous studies using IBD-SES in the USA or Canada, scores observed with Japanese IBD patients are lower. It might reflect a cultural difference.

scholarly journals CDC Grand Rounds: Improving Medication Adherence for Chronic Disease Management — Innovations and Opportunities

2017 ◽  
Vol 66 (45) ◽  
pp. 1248-1251 ◽  
Author(s):  
Andrea B. Neiman ◽  
Todd Ruppar ◽  
Michael Ho ◽  
Larry Garber ◽  
Paul J. Weidle ◽  
...  
Keyword(s):  
Chronic Disease ◽  
Medication Adherence ◽  
Disease Management ◽  
Chronic Disease Management ◽  
Grand Rounds

scholarly journals The Effect of Chronic Disease Management on the Treat-to-Target of Gout: A Cross-Sectional Study

2021 ◽  
Author(s):  
Ertao Jia ◽  
Shasha Hu ◽  
Zhiying Zhan ◽  
Wukai Ma ◽  
Hongling Geng ◽  
...  
Keyword(s):  
Chronic Disease ◽  
Medication Adherence ◽  
Disease Management ◽  
Chronic Disease Management ◽  
Popular Science ◽  
Cross Sectional Study ◽  
Treat To Target ◽  
Sectional Study ◽  
Cross Sectional ◽  
Poor Medication Adherence

Abstract Background: The treat-to-target (T2T) strategy is essential for patients with gout. However, the rate of T2T is low. This study aimed to explore doctor-led chronic disease management on the T2T of gout, survey the rate of T2T and assess the predictors associated with poor control of serum urate levels (SUA) in a large population of patients with gout receiving urate-lowering treatment (ULT). Methods: A multi-center, cross-sectional study was conducted. We surveyed the relevant information of outpatients who received ULT for more than six months using electronic questionnaires, including demographics, disease-related conditions, comorbid conditions, and management. The patients with gout were divided into the SUA > 360 µmol/L and ≤ 360 µmol/L, and the patient characteristics between the two groups were compared. We analyzed the predictors of SUA > 360 µmol/L and poor disease control.Results: We collected 425 (90.8% of the patients) valid questionnaires. There were significant differences in the gender, education level, regular visits, medication adherence, diabetes, economic burden and community doctor's help between the SUA > 360 µmol/L (n=311, 73.18%) and ≤ 360 µmol/L (n=114, 26.82%) groups. The predictors of SUA >360 µmol/L were general medication adherence (OR=2.35; 95% CI 1.17–4.77; p=0.016), poor medication adherence (OR=4.63; 95% CI 2.28–9.51; p<0.001) and community doctor’s help (OR=0.60; 95% CI 0.37–0.97; p=0.036 for full model, OR=0.58; 95% CI 0.36–0.93; p=0.023 for simplified model). There were significant differences in the gender, regular visits, medication adherence, gout popular science, established health files, and community doctor’s help between the not well controlled (n=361, 84.94%) and well controlled (n=61, 14.35%) groups. The predictors of not well controlled were Tophi (OR=2.48; 95% CI 1.17–5.61; p=0.023), general medication adherence (OR=2.78; 95% CI 1.28–6.05; p=0.009), poor medication adherence (OR=6.23; 95% CI 2.68–14.77; p<0.001) and no gout popular science (OR=4.07; 95% CI 1.41–13.91; p=0.015).Conclusion: The T2T and well controlled rates were very low. The medication adherence, the community doctor’s help and gout popular science which was the doctor-led chronic gout management should be further improved to increase the T2T and well controlled rate.Trial registration: ChiCTR, ChiCTR2000034700, Registered 15 July 2020. http://www.chictr.org.cn/showproj.aspx?proj=55778

Sign in / Sign up

Export Citation Format

Share Document